← All stocks

RxSight, Inc.

RXST Net selling
CIK 0001111485 #3743 in the set updated 17 Sep 2026
Bought (120 mo)
$23.43M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$63.11M
$15.60M on a plan · $15.20M straight out of an exercise
Sold at will
$32.31M
17 of 129 sales
Net
−$39.68M
−$8.88M against sales at will

By person

19 insiders · 171 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Tammenoms Bakker Juliet
Director
$16.91M (7)
$30.74M (10)
−$13.82M
586,731
1.41%
$4.08M
+17.3%
Thunen Shelley B
See remarks
$8.54M (26) scheduled
−$8.54M
38,354
0.0922%
$266.94K
−24.5%
Goldshleger Ilya
Chief Operating Officer
$33.27K (2)
$8.03M (60) scheduled
−$8.00M
82,881
0.1993%
$576.85K
Kurtz Ronald M MD
Chief Medical Officer
$2.05M (2)
$7.72M (7) scheduled
−$5.67M
1,600,995
3.85%
$11.14M
+2.3%
Corley Jesse Anderson
Director
$2.47M (8)
$571.53K (3) scheduled
+$1.89M
525,638
1.26%
$3.66M
+78.6%
Weinberg Eric
See remarks
$515.24K (6)
$2.27M (7) scheduled
−$1.76M
837,322
2.01%
$5.83M
+33.2%
Warner Robert Keith
Director
$700.00K (1)
$1.71M (4) scheduled
−$1.01M
135,204
0.3251%
$941.02K
+136.7%
Maniar Shweta
Director
$983.95K (6) scheduled
−$983.95K
55,172
0.1326%
$384.00K
LINK WILLIAM J PHD
Director
$500.00K (1)
$1.40M (2)
−$903.12K
2,112,918
5.08%
$14.71M
−7.0%
Andrews Julie
Director
$250.00K (1)
$906.29K (2) scheduled
−$656.29K
78,076
0.1877%
$543.41K
Fountain Tamara
Director
$180.00K (1) scheduled
−$180.00K
72,582
0.1745%
$505.17K
Wilterding Mark
Chief Financial Officer
$54.04K (1)
−$54.04K
25,049
0.0602%
$174.34K
RxSight I, LLC entity
10% owner
2,016,778
4.85%
$14.04M
Wolfen Richard M.
Director
1,840,244
4.42%
$12.81M
+572.9%
Robertson Bruce C
Director
1,385,037
3.33%
$9.64M
Schwartz Daniel Mark
Director
407,647
0.9801%
$2.84M
+1.0%
PALMISANO ROBERT J
Director
78,076
0.1877%
$543.41K
COHEN RAYMOND W
Director
66,532
0.1600%
$463.06K
Gaines Scott
Chief Customer Officer
14,848
0.0357%
$103.34K
+33.0%
Insider
Date
Role
Action
Shares
Price
Amount
Corley Jesse Anderson
16 Jan 2025
Director
Buy indirect
1,767
$31.13
$55.00K
Corley Jesse Anderson
15 Jan 2025
Director
Buy indirect
1,443
$31.19
$45.00K
Corley Jesse Anderson
13 Nov 2024
Director
Buy
1,705
$44.50
$75.87K
Corley Jesse Anderson
13 Nov 2024
Director
Buy
4,090
$44.98
$183.97K
Corley Jesse Anderson
13 Nov 2024
Director
Buy indirect
5,570
$45.00
$250.65K
Corley Jesse Anderson
12 Nov 2024
Director
Buy indirect
11,111
$45.37
$504.08K
Tammenoms Bakker Juliet
17 May 2024
Director
Buy
5,000
$61.09
$305.46K
Tammenoms Bakker Juliet
14 Feb 2024
Director
Buy
4,000
$51.29
$205.15K
Tammenoms Bakker Juliet
12 Feb 2024
Director
Buy
4,000
$50.38
$201.52K
Tammenoms Bakker Juliet
10 Feb 2023
Director
Buy indirect
480,000
$12.50
$6.00M
Corley Jesse Anderson
17 Nov 2021
Director
Buy
8,150
$12.49
$101.75K
Kurtz Ronald M MD
5 Aug 2021
See Remarks
Buy indirect
3,638
$13.85
$50.38K
Weinberg Eric
5 Aug 2021
Chief Commercial Officer
Buy indirect
9
$14.90
$134.10
Goldshleger Ilya
5 Aug 2021
Chief Operating Officer
Buy indirect
1,372
$13.69
$18.78K
Goldshleger Ilya
5 Aug 2021
Chief Operating Officer
Buy
1,000
$14.49
$14.49K
Weinberg Eric
4 Aug 2021
Chief Commercial Officer
Buy indirect
615
$16.25
$9.99K
Warner Robert Keith
3 Aug 2021
Director
Buy indirect
43,750
$16.00
$700.00K
Andrews Julie
3 Aug 2021
Director
Buy
15,625
$16.00
$250.00K
Kurtz Ronald M MD
3 Aug 2021
See Remarks
Buy
125,000
$16.00
$2.00M
Weinberg Eric
3 Aug 2021
Chief Commercial Officer
Buy
31,250
$16.00
$500.00K
LINK WILLIAM J PHD
3 Aug 2021
Director
Buy
31,250
$16.00
$500.00K
Corley Jesse Anderson
3 Aug 2021
Director
Buy indirect
78,125
$16.00
$1.25M
Tammenoms Bakker Juliet
3 Aug 2021
Director
Buy indirect
500,000
$16.00
$8.00M
Tammenoms Bakker Juliet
3 Aug 2021
Director
Buy indirect
125,000
$16.00
$2.00M
Tammenoms Bakker Juliet
3 Aug 2021
Director
Buy
12,500
$16.00
$200.00K
Weinberg Eric
3 Aug 2021
Chief Commercial Officer
Buy indirect
1
$17.03
$17.03
Weinberg Eric
2 Aug 2021
Chief Commercial Officer
Buy indirect
90
$17.04
$1.53K
Weinberg Eric
30 Jul 2021
Chief Commercial Officer
Buy indirect
210
$16.94
$3.56K

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 39
Sales straight out of an exercise 73
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 15,865,409
History held since 2 Aug 2021